BioCentury
ARTICLE | Company News

Pathwork, Novartis in biomarker discovery deal

July 30, 2010 11:50 PM UTC

Pathwork Diagnostics Inc. (Redwood City, Calif.) and Novartis AG (NYSE:NVS; SIX:NOVN) partnered to discover cancer biomarkers. Both companies will have rights to develop and commercialize diagnostics ...